Close filters
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
from to

Products from peptides&elephants GmbH

Filter
No results were found for the filter!
NEW
Delta Variant B.1.617.2 Peptide Pool SARS-CoV-2 (Spike Glycoprotein) Delta Variant B.1.617.2 Peptide Pool SARS-CoV-2...
This peptide pool with 27 peptides covers all mutations in the Spike Glycoprotein derived from the delta variant B.1.617.2 of SARS-CoV-2 which is prevalent in India and carries the L452R spike mutation, among others.
€200.00 *
NEW
Alpha Variant B.1.1.7 Peptide Pool SARS-CoV-2 (Spike Glycoprotein) Alpha Variant B.1.1.7 Peptide Pool SARS-CoV-2...
This peptide pool with 31 peptides covers all mutations in the Spike Glycoprotein derived from the alpha variant B.1.1.7 of SARS-CoV-2 which emerged in Britain in December 2020 and is thought to be roughly 50 percent more infectious and...
€200.00 *
NEW
Beta Variant B.1.351 Peptide Pool SARS-CoV-2 (Spike Glycoprotein) Beta Variant B.1.351 Peptide Pool SARS-CoV-2...
This peptide pool with 34 peptides covers all mutations in the Spike Glycoprotein derived from the beta variant B.1.351 of SARS-CoV-2 which emerged in South Africa in December 2020 and reduces the effectiveness of some vaccines.
€200.00 *
NEW
Gamma Variant P.1 Peptide Pool SARS-CoV-2 (Spike Glycoprotein) Gamma Variant P.1 Peptide Pool SARS-CoV-2...
This peptide pool with 36 peptides covers all mutations in the Spike Glycoprotein derived from the gamma variant P.1 of SARS-CoV-2 which emerged in Brazil in late 2020 and has similar mutations to the beta variant B.1.351.
€200.00 *
NEW
CMV Sub Peptide Pool (>95% HPLC) CMV Sub Peptide Pool (>95% HPLC)
This pool consists of 14 peptides, each corresponding to a defined HLA class I-restricted T cell epitope from cytomegalovirus (CMV).
€55.00 *
NEW
HBV Sub Peptide Pool (>95% HPLC) HBV Sub Peptide Pool (>95% HPLC)
This pool consists of 9 peptides, each corresponding to a defined HLA class I-restricted T cell epitope from Hepatitis B virus (HBV).
€55.00 *
NEW
RSV Sub Peptide Pool (>95% HPLC) RSV Sub Peptide Pool (>95% HPLC)
This pool consists of 28 peptides, each corresponding to a defined HLA class I-restricted T cell epitope from Respiratory Syncytial Virus (RSV).
€55.00 *
NEW
EBV LMP-2 340-349 mutant (HLA-A*11:01) 348T EBV LMP-2 340-349 mutant (HLA-A*11:01) 348T
SSCSSCPLTK is a linear mutated peptidic epitope (epitope ID60930) studied as part of Latent membrane protein 2 from Human herpesvirus 4 (Epstein Barr virus). This epitope has been studied for immune reactivity, tested in T cell assays...
From €50.00 *
Details
NEW
Proinsulin 90-104 Proinsulin 90-104
This is a Proinsulin-derived peptide of GIVEQCCTSICSLYQ sequence covering 90-104 and DRB1*04:01 molecule.
From €100.00 *
Details
ACTH (1-39) (human) ACTH (1-39) (human)
ACTH (1-39), human is a synthetic peptide corresponding to the first 39 amino acids of human ACTH/adrenocorticotropin which is the major regulator of adrenal cortex function. ACTH stimulates the synthesis of steroidal hormones.
From €210.00 *
Details
ACTH (18-39) (human) ACTH (18-39) (human)
Adrenocorticotropic hormone (ACTH) (18-39) is a C-terminal peptide fragment of ACTH, a peptide hormone found in the brain that is involved in the biological stress response. ACTH is produced in the anterior pituitary gland upon...
From €150.00 *
Details
MBP (54-72) human MBP (54-72) human
MBP (54-72) human - SHHAARTTHYGSLPQKSQR represents a short peptide sequence of the protein lipid part of the myelin sheath. Such proteins are obviously targets of the immune defense in multiple sclerosis.
From €170.00 *
Details
MOG 97-108 MOG 97-108
Myelin oligodendrocyte glycoprotein (MOG)97 - 108, a minor component of CNS myelin, is expressed in central nervous system myelin which produces a relapsing-remitting neurological diesease with extensive plague-like demyelination. It is...
From €100.00 *
Details
Fibromodulin F4 226-235 (HLA-A*02:01) Fibromodulin F4 226-235 (HLA-A*02:01)
YLLDLSYNHL (HLA-A*0201) is a single peptide for stimulation of T cells. The peptide from tumor-associated antigen Fibromodulin F4 is synthesized as it is presented by the MHC class I HLA-A*0201 allele and can be used for targeted in...
From €50.00 *
Details
LCMV GP (33-41) (H-2 Db) LCMV GP (33-41) (H-2 Db)
Antigen Peptide Pre-glycoprotein polyprotein H-2 Db (KAVYNFATM) for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays. LCMV gp33 peptide KAVYNFATM (H-2 Db) is a single...
From €50.00 *
Details
FLAG FLAG
This epitope tag is a short hydrophilic, highly charged peptide. It is the most widely used epitope tag employed in structural and functional studies of proteins.
From €80.00 *
Details
MOG 40-54 MOG 40-54
Myelin oligodendrocyte glycoprotein (MOG) 40-54, a minor component of CNS myelin, is expressed in central nervous system myelin which produces a relapsing-remitting neurological diesease with extensive plague-like demyelination. It is...
From €100.00 *
Details
MOG 40-55 MOG 40-55
Myelin oligodendrocyte glycoprotein (MOG) 40-55, a minor component of CNS myelin, is expressed in central nervous system myelin which produces a relapsing-remitting neurological diesease with extensive plague-like demyelination. It is...
From €100.00 *
Details
MOG 94 - 110, human MOG 94 - 110, human
Myelin oligodendrocyte glycoprotein (MOG)94 - 110, a minor component of CNS myelin, is expressed in central nervous system myelin which produces a relapsing-remitting neurological diesease with extensive plague-like demyelination. It is...
From €170.00 *
Details
MBP (63–81) MBP (63–81)
#
From €130.00 *
Details
EBV EBNA-1 407-417 mutant (HLA-B*35:01) 410A EBV EBNA-1 407-417 mutant (HLA-B*35:01) 410A
EBNA1-derived peptide of HPVAEADYFEY covering 407-417 and B*35:08 molecule. HPVAEADYFEY is a linear peptidic epitope (epitope ID 227777) studied as part of Epstein-Barr nuclear antigen 1 from Human herpesvirus 4 (Epstein Barr virus)....
From €80.00 *
Details
EBV EBNA-1 407-417 mutant (HLA-B*35:08) 411D EBV EBNA-1 407-417 mutant (HLA-B*35:08) 411D
EBV EBNA1-derived peptide of HPVGDADYFEY covering 407-417 and B*35:08 molecule. HPVGDADYFEY is a linear peptidic epitope (epitope ID 24525) studied as part of Epstein-Barr nuclear antigen 1 from Human herpesvirus 4 (Epstein Barr virus)....
From €80.00 *
Details
gp100 17-25 (HLA-A*03:01) gp100 17-25 (HLA-A*03:01)
#
From €50.00 *
Details
gp100 170-178 (HLA-A*24:02) gp100 170-178 (HLA-A*24:02)
This peptide is a tetramer of biotinylated peptide with streptavidin mainly composed of gp100-intron 4-derived peptide of VYFFLPDHL sequence covering 170-178 and A*24:02 molecule. The pMHC tetramer recognizes human CD8 T cells, and can...
From €50.00 *
Details
LCMV envelope gp 10-18 (HLA-A*02:01) LCMV envelope gp 10-18 (HLA-A*02:01)
ALPHIIDEV is a linear peptidic epitope (epitope ID2814) studied as part of Pre-glycoprotein polyprotein GP complex from Lymphocytic choriomeningitis mammarenavirus. This epitope has been studied for immune reactivity, tested in T cell...
From €50.00 *
Details
HIV env 816-825 (HLA-A*02:01) HIV env 816-825 (HLA-A*02:01)
Correlation between HLA class I and spontaneous control of HIV-1 was significant for 7-8 epitopes when 341 chronic, HIV-infected subjects, divided into controllers and non-controllers, were tested for EliSpot responses to 257 optimally...
From €50.00 *
Details
HIV Env 586-593 (HLA-B*08:01) HIV Env 586-593 (HLA-B*08:01)
This peptide has a high avidity for CD8 T cells, and can be used in the analysis of individual antigen-specific T cells. This product is a MHC pentamer of peptide composed Env-derived peptide of YLKDQQLL sequence covering 586-593 and...
From €50.00 *
Details
RSV MP 229-237 (HLA-A*01:01) RSV MP 229-237 (HLA-A*01:01)
#
From €50.00 *
Details
RSV Fusion protein 540-548 (HLA-A*02:01) RSV Fusion protein 540-548 (HLA-A*02:01)
#
From €50.00 *
Details
Epsilon Variant (B.1.427/B.1.429) Peptide Pool SARS-CoV-2 (Spike Glycoprotein) Epsilon Variant (B.1.427/B.1.429) Peptide Pool...
This peptide pool with 14 peptides covers all mutations in the Spike Glycoprotein derived from the epsilon variant B.1.427/B.1.429 of SARS-CoV-2 which emerged in the US in March 2020.
€200.00 *
Zeta Variant (P.2) Peptide Pool SARS-CoV-2 (Spike Glycoprotein) Zeta Variant (P.2) Peptide Pool SARS-CoV-2...
This peptide pool with 12 peptides covers all mutations in the Spike Glycoprotein derived from the zeta variant P.2 of SARS-CoV-2 which emerged in Brazil in April 2020.
€200.00 *
Eta Variant (B.1.525) Peptide Pool SARS-CoV-2 (Spike Glycoprotein) Eta Variant (B.1.525) Peptide Pool SARS-CoV-2...
This peptide pool with 31 peptides covers all mutations in the Spike Glycoprotein derived from the eta variant B.1.525 of SARS-CoV-2 which emerged in Angola in December 2020.
€200.00 *
Theta Variant (P.3) Peptide Pool SARS-CoV-2 (Spike Glycoprotein) Theta Variant (P.3) Peptide Pool SARS-CoV-2...
This peptide pool with 30 peptides covers all mutations in the Spike Glycoprotein derived from the theta variant P.3 of SARS-CoV-2 which emerged in the Philippines in January 2021.
€200.00 *
Iota Variant (B.1.526) Peptide Pool SARS-CoV-2 (Spike Glycoprotein) Iota Variant (B.1.526) Peptide Pool SARS-CoV-2...
This peptide pool with 21 peptides covers all mutations in the Spike Glycoprotein derived from the iota variant B.1.526 of SARS-CoV-2 which emerged in the US in November 2020.
€200.00 *
Kappa Variant (B.1.617.1) Peptide Pool SARS-CoV-2 (Spike Glycoprotein) Kappa Variant (B.1.617.1) Peptide Pool...
This peptide pool with 25 peptides covers all mutations in the Spike Glycoprotein derived from the kappa variant B.1.617.1 of SARS-CoV-2 which emerged in India in October 2020.
€200.00 *
Lambda Variant (C.37) Peptide Pool SARS-CoV-2 (Spike Glycoprotein) Lambda Variant (C.37) Peptide Pool SARS-CoV-2...
This peptide pool with 25 peptides covers all mutations in the Spike Glycoprotein derived from the lambda variant C.37 of SARS-CoV-2 which emerged in Peru in August 2020.
€200.00 *
MOG 35-52 MOG 35-52
Myelin oligodendrocyte glycoprotein (MOG) 35-52, a minor component of CNS myelin, is expressed in central nervous system myelin which produces a relapsing-remitting neurological diesease with extensive plague-like demyelination. It is...
From €170.00 *
Details
MOG 38-53 MOG 38-53
Myelin oligodendrocyte glycoprotein (MOG) 38-53, a minor component of CNS myelin, is expressed in central nervous system myelin which produces a relapsing-remitting neurological diesease with extensive plague-like demyelination. It is...
From €100.00 *
Details
MOG 37–54, mouse, rat MOG 37–54, mouse, rat
Myelin oligodendrocyte glycoprotein (MOG) 37–54, a minor component of CNS myelin, is expressed in central nervous system myelin which produces a relapsing-remitting neurological diesease with extensive plague-like demyelination. It is...
From €100.00 *
Details
MOG 35 - 53 MOG 35 - 53
Myelin oligodendrocyte glycoprotein (MOG) 35-53, a minor component of CNS myelin, is expressed in central nervous system myelin which produces a relapsing-remitting neurological diesease with extensive plague-like demyelination. It is...
From €170.00 *
Details
MOG 35 - 51 MOG 35 - 51
Myelin oligodendrocyte glycoprotein (MOG) 35-51, a minor component of CNS myelin, is expressed in central nervous system myelin which produces a relapsing-remitting neurological diesease with extensive plague-like demyelination. It is...
From €170.00 *
Details
MOG 27 - 50, human MOG 27 - 50, human
Myelin oligodendrocyte glycoprotein (MOG) 27-50, a minor component of CNS myelin, is expressed in central nervous system myelin which produces a relapsing-remitting neurological diesease with extensive plague-like demyelination. It is...
From €230.00 *
Details
MOG 14 - 39, human MOG 14 - 39, human
Myelin oligodendrocyte glycoprotein (MOG) 14 - 39, a minor component of CNS myelin, is expressed in central nervous system myelin which produces a relapsing-remitting neurological diesease with extensive plague-like demyelination. It is...
From €230.00 *
Details
MOG 8 - 22, rat MOG 8 - 22, rat
Myelin oligodendrocyte glycoprotein (MOG) 8 - 22, a minor component of CNS myelin, is expressed in central nervous system myelin which produces a relapsing-remitting neurological diesease with extensive plague-like demyelination. It is...
From €100.00 *
Details
MOG 8 - 21 MOG 8 - 21
Myelin oligodendrocyte glycoprotein (MOG) 8 - 21, a minor component of CNS myelin, is expressed in central nervous system myelin which produces a relapsing-remitting neurological diesease with extensive plague-like demyelination. It is...
From €100.00 *
Details
MOG 1 - 26, human MOG 1 - 26, human
Myelin oligodendrocyte glycoprotein (MOG) 1 - 26, a minor component of CNS myelin, is expressed in central nervous system myelin which produces a relapsing-remitting neurological diesease with extensive plague-like demyelination. It is...
From €230.00 *
Details
MOG 1 - 21, rat MOG 1 - 21, rat
Myelin oligodendrocyte glycoprotein (MOG) 1 - 21, a minor component of CNS myelin, is expressed in central nervous system myelin which produces a relapsing-remitting neurological diesease with extensive plague-like demyelination. It is...
From €210.00 *
Details
CyLoP-1 CyLoP-1
CyLoP-1 is a cysteine-rich cell-penetrating peptide derived from nuclear localization sequence of snake toxin, crotamine. The peptide has shown cytoplasmic uptake in mammalian cells at lower concentrations. In the present study, the...
From €120.00 *
Details
HIV TAT (47-57) HIV TAT (47-57)
TAT protein is the nuclear transcriptional activator of viral gene expression in HIV proliferation. The TAT peptide corresponds to the polycationic aa47-57 region of TAT protein. TAT peptide is a cell-penetrating peptide (CPP) used to...
From €65.00 *
Details
HIV TAT (48-60) HIV TAT (48-60)
Peptide derived from the HIV transactivator of transcription protein. TAT is a cationic cell-penetrating peptide.
From €75.00 *
Details
Arg9_Amide Arg9_Amide
This is a peptide comprising of 9 arginine residues. It has been shown that poly-Arg peptides composed of 9 arginine residues are able to efficiently translocate across cells. It has also been shown in model systems that Arg-9...
From €50.00 *
Details
Arg9 Arg9
This is a peptide comprising of 9 arginine residues. It has been shown that poly-Arg peptides composed of 9 arginine residues are able to efficiently translocate across cells. It has also been shown in model systems that Arg-9...
From €50.00 *
Details
LCMV GP 64-80 LCMV GP 64-80
#
From €130.00 *
Details
PLP (178-191) PLP (178-191)
NTWTTCQSIAFPSK represents a short peptide sequence of the protein lipid portion of the myelin sheath. Proteins of the myelin sheath are obvious targets of immune defense in multiple sclerosis.
From €85.00 *
Details
PLP (139-151) PLP (139-151)
This is amino acid residue 139 to 151 of myelin proteolipid protein (PLP). This peptide is used to induce relapsing-remitting (RR)-EAE model.
From €85.00 *
Details
MBP (1-11) human MBP (1-11) human
MBP (1-11) human - ASQKRPSQRHG represents a short peptide sequence of the protein lipid part of the myelin sheath. Such proteins are obviously targets of the immune defense in multiple sclerosis.
From €50.00 *
Details
MOG 91 - 108, rat MOG 91 - 108, rat
Myelin oligodendrocyte glycoprotein (MOG) 91 - 108, a minor component of CNS myelin, is expressed in central nervous system myelin which produces a relapsing-remitting neurological diesease with extensive plague-like demyelination. It is...
From €170.00 *
Details
MOG 183-191 MOG 183-191
Myelin oligodendrocyte glycoprotein (MOG) 183-191, a minor component of CNS myelin, is expressed in central nervous system myelin which produces a relapsing-remitting neurological diesease with extensive plague-like demyelination. It is...
From €50.00 *
Details
MOG 92-106 MOG 92-106
Myelin oligodendrocyte glycoprotein (MOG)92-106, a minor component of CNS myelin, is expressed in central nervous system myelin which produces a relapsing-remitting neurological diesease with extensive plague-like demyelination. It is...
From €100.00 *
Details
MOG 35-55 human MOG 35-55 human
Myelin oligodendrocyte glycoprotein (MOG) 35-55, a minor component of CNS myelin, is expressed in central nervous system myelin which produces a relapsing-remitting neurological diesease with extensive plague-like demyelination. It is...
From €100.00 *
Details
Melan - A, MART 1 (26 - 35) Melan - A, MART 1 (26 - 35)
This native Melan-A (26-35) decapeptide is an immunodominant antigen from melanocyte/melanoma (Melan-A/MART) protein that is more efficiently recognized by tumor-infiltrating lymphocytes (TILs) of melanoma patients than the Melan-A...
From €50.00 *
Details
MAGE-A3 271-279 (HLA-A*02:01) MAGE-A3 271-279 (HLA-A*02:01)
FLWGPRALV is a linear peptidic epitope (epitope ID16970) studied as part of Melanoma-associated antigen 3 from Homo sapiens (human). This epitope has been studied for immune reactivity, tested in T cell assays and MHC ligand assays
From €50.00 *
Details
HCV NS5b 2594-2602 mutant (HLA-A*02:01) 2600S HCV NS5b 2594-2602 mutant (HLA-A*02:01) 2600S
#
From €50.00 *
Details
SARS-CoV-2 (ORF9b) Peptide Pool SARS-CoV-2 (ORF9b) Peptide Pool
Pool of 22 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through the entire Protein 9b (UniProt: P0DTD2) of SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) for T cell assays (e.g. ELISPOT)
€150.00 *
SARS-CoV-2 (NS7b) Peptide Pool SARS-CoV-2 (NS7b) Peptide Pool
Pool of 8 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through the entire Non-structural Protein 7b (UniProt: P0DTD8) of SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) for T cell...
€150.00 *
SARS-CoV-2 (ORF3a) Peptide Pool SARS-CoV-2 (ORF3a) Peptide Pool
Pool of 66 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through Protein ORF3a (UniProt: P0DTC3) of SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) for T cell assays (e.g. ELISPOT).
€200.00 *
SARS-CoV-2 (N-Protein) Peptide Pool SARS-CoV-2 (N-Protein) Peptide Pool
Pool of 102 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through Nucleoprotein (UniProt: P0DTC9) of SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) for T cell assays (e.g. ELISPOT).
€200.00 *
SARS-CoV-2 (ORF9c) Peptide Pool SARS-CoV-2 (ORF9c) Peptide Pool
Pool of 16 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through Uncharacterized ORF9c protein (UniProt: P0DTD3) of SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) for T cell assays...
€150.00 *
SARS-CoV-2 (M-Protein) Peptide Pool SARS-CoV-2 (M-Protein) Peptide Pool
Pool of 53 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through Membrane protein (UniProt: P0DTC5) of SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) for T cell assays (e.g. ELISPOT)
€175.00 *
NS5B 2936-2944 (HLA-B*27:05) NS5B 2936-2944 (HLA-B*27:05)
#
From €50.00 *
Details
Human HLA-A*02, A*24 leader 3-11 (HLA-A*02) Human HLA-A*02, A*24 leader 3-11 (HLA-A*02)
HLA-A leader 3-11-derived peptide of VMAPRTLVL sequence covering 3-11 and HLA-E*01:03 molecule. VMAPRTLVL is a linear peptidic epitope (epitope ID69922) studied as part of HLA class I histocompatibility antigen, A-68 alpha chain from...
From €50.00 *
Details
Larazotide (AT-1001) Larazotide (AT-1001)
Larazotide (INN; also known as AT-1001; formulated as the salt with acetic acid, larazotide acetate) is a synthetic eight amino acid peptide that functions as a tight junction regulator and reverses leaky junctions to their normally...
From €70.00 *
Details
OVA 257-268 (H-2 Kb) OVA 257-268 (H-2 Kb)
SIIVFEKL is a linear peptidic epitope, tested in T cell assays and MHC ligand assay.
From €50.00 *
Details
B8R 20-27 (H-2 Kb) B8R 20-27 (H-2 Kb)
This is amino acids 20 to 27 fragment of B8R, a vaccinia virus (VV) gene that encodes a secreted protein related to gamma interferon receptor (IFN-?). B8R binding to IFN-? neutralizes its antiviral activity.
From €50.00 *
Details
HPV E6 29-38 (HLA-A*02:01) HPV E6 29-38 (HLA-A*02:01)
TIHDIILECV is a linear peptidic epitope (epitope ID64320) studied as part of Protein E6 from Alphapapillomavirus 9. This epitope has been studied for immune reactivity, tested in T cell assays and MHC ligand assays
From €50.00 *
Details
HCV NS5B 2594-2602 (HLA-A*02:01) HCV NS5B 2594-2602 (HLA-A*02:01)
ALYDVVTKL is a linear peptidic epitope studied as part of Genome polyprotein from Hepatitis C virus.
From €50.00 *
Details
HCMV IE-1 378-389 (HLA-B18) HCMV IE-1 378-389 (HLA-B18)
HLA-B18-restricted epitope from Cytomegalovirus (378-389)
From €80.00 *
Details
EBV LMP-2 426-434 (HLA-A*02:01) EBV LMP-2 426-434 (HLA-A*02:01)
EBV LMP-2 426-434 (HLA-A*02:01) CLGGLLTMV for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.
From €50.00 *
Details
EBV EBNA-1 407-417 (HLA-B*35:01) EBV EBNA-1 407-417 (HLA-B*35:01)
Antigen Peptide EBV EBNA-1 407-417 (HLA-B*35:01) HPVGEADYFEY for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays. HPVGEADYFEY for stimulation of human EBV EBNA-1-specific...
From €50.00 *
Details
PRAME 425-433 (HLA-A*02:01) PRAME 425-433 (HLA-A*02:01)
#
From €50.00 *
Details
HCMVlfl HCMVlfl
VMAPRTLFL is a linear peptidic epitope (epitope ID99045) studied as part of HLA class I histocompatibility antigen, alpha chain G from Homo sapiens (human). This epitope has been studied for immune reactivity, tested in T cell assays,...
From €50.00 *
Details
MOG-Peptid 35-55 MOG-Peptid 35-55
Myelin oligodendrocyte glycoprotein (MOG)35-55, a minor component of CNS myelin, is expressed in central nervous system myelin which produces a relapsing-remitting neurological diesease with extensive plague-like demyelination. It is...
From €100.00 *
Details
CRGDS CRGDS
GRGDS forms the cell-binding domain of a glycoprotein, Osteopontin (OPN) . Although the native form of OPN is active in cell attachment assays, it has been observed that thrombin cleavage of OPN causes substantial enhancement of it's...
From €50.00 *
Details
HIV-1 RT 476-484 (HLA-A*02:01) HIV-1 RT 476-484 (HLA-A*02:01)
ILKEPVHGV is a linear peptidic epitope studied as part of Gag-Pol polyprotein from Human immunodeficiency virus 1. HIV pol peptide ILKEPVHGV (HLA-A*0201) for stimulation of human HIV pol-specific CD8+ T-cells. The peptide is synthesised...
From €50.00 *
Details
NS2A 4–13 (HLA-C*03:04) NS2A 4–13 (HLA-C*03:04)
#
From €50.00 *
Details
LCMV gp 276-286 (H-2 Db) LCMV gp 276-286 (H-2 Db)
SGVENPGGYCL (H-2 Db) is a single peptide for stimulation of T cells. The peptide from lymphocytic choreomeningitis virus (LCMV) glycoprotein (gp) is synthesized as it is presented by the MHC class I H-2 Db allele and can be used for...
From €50.00 *
Details
HCV Polyprotein 1406-1415 (HLA-A*02:01) HCV Polyprotein 1406-1415 (HLA-A*02:01)
KLVALGINAV is a linear peptidic epitope studied as part of Genome polyprotein from Hepatitis C virus. Single peptide (KLVALGINAV) for stimulation of human HCV NS3 (1406-1415)-specific CD8+ T cells. The peptide is synthesised as it is...
From €50.00 *
Details
PPI 2-10 (HLA-A*02:01) PPI 2-10 (HLA-A*02:01)
ALWMRLLPL (HLA-A*0201) is a single peptide for stimulation of T cells. The peptide from preproinsulin (PPI) is synthesized as it is presented by the MHC class I HLA-A*0201 allele and can be used for targeted in vitro generation and...
From €50.00 *
Details
ADV Hexon 917-925 (HLA-A*02:01) ADV Hexon 917-925 (HLA-A*02:01)
Single peptide (YVLFEVFDV) for stimulation of human ADV Hexon (917-925)-specific CD8+ T cells. The peptide is synthesised as it is presented by the MHC class I HLA-A*02:01 allele. Lyophilized powder. Purity > 95 %, endotoxin free.
From €50.00 *
Details
Survivin 5-14 (HLA-A*0201) Survivin 5-14 (HLA-A*0201)
Single peptide (TLPPAWQPFL) for stimulation of human Survivin (5-14)-specific CD8+ T-cells. The peptide is synthesised as it is presented by the MHC class I HLA-A*02:01 allele.
From €50.00 *
Details
Cyclin A1 227-235 (HLA-A*02:01) Cyclin A1 227-235 (HLA-A*02:01)
FLDRFLSCM (HLA-A*0201) is a single peptide for stimulation of T cells. The peptide from Cyclin A1 is synthesized as it is presented by the MHC class I HLA-A*0201 allele and can be used for targeted in vitro generation and expansion of...
From €50.00 *
Details
HCMV pp65-265-275(HLA-B*07:02) HCMV pp65-265-275(HLA-B*07:02)
RPHERNGFTVL is a linear peptidic epitope (epitope ID55170) studied as part of 65 kDa phosphoprotein from Human herpesvirus 5 (Human cytomegalovirus). This epitope has been studied for immune reactivity, tested in T cell assays and MHC...
From €50.00 *
Details
CD79b 52-60 (HLA-A*0201) CD79b 52-60 (HLA-A*0201)
Antigen Peptide CD antigen HLA-A*0203 (TLKDGIIMI) for stimulation of antigen-specific T cells in T cell assays
From €50.00 *
Details
SARS-CoV-2 NCAP A2 (N223-231) SARS-CoV-2 NCAP A2 (N223-231)
SARS-CoV-2 peptide LLLDRLNQL (HLA-A*0201) for stimulation of T-cells. Single peptide (LLLDRLNQL) for stimulation of human SARS-CoV-2-specific CD8+ T-cells.
From €50.00 *
Details
UTA2-1 248-256 (HLA-A*02:01) UTA2-1 248-256 (HLA-A*02:01)
Antigene peptide for stimulation of human UTA2-1(248-256)-specific CD8+T cells. The peptide is synthesised as it is presented by the MHC class I HLA-A*02:01 allele.
From €50.00 *
Details
FAP 735-744 (HLA-A*02:01) FAP 735-744 (HLA-A*02:01)
GLSGLSTNHL (HLA-A*0201) is a single peptide for stimulation of T cells. The peptide from fibroblast activation protein (FAP) is synthesized as it is presented by the MHC class I HLA-A*0201 allele and can be used for targeted in vitro...
From €50.00 *
Details
Fibromodulin F3 250-259 (HLA-A*02:01) Fibromodulin F3 250-259 (HLA-A*02:01)
Antigen Peptide Fibromodulin HLA-A*02:01 (YMEHNNVYTV) for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.
From €50.00 *
Details
Fibromodulin F2 206-215 (HLA-A*02:01) Fibromodulin F2 206-215 (HLA-A*02:01)
Antigen Peptide Fibromodulin HLA-A*02:01 (YLQHNEIQEV) for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.
From €50.00 *
Details
Fibromodulin F1 7-17 (HLA-A*02:01) Fibromodulin F1 7-17 (HLA-A*02:01)
Antigen Peptide Fibromodulin HLA-A*02:01 (LLLAGLFSL) for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.
From €50.00 *
Details
HsPSMA 634-642 (H-2 Db) HsPSMA 634-642 (H-2 Db)
SAVKNFTEI (H-2 Db) is a single peptide for stimulation of T cells. The peptide from HsPSMA is synthesized as it is presented by the MHC class I H-2 Db allele and can be used for targeted in vitro generation and expansion of...
From €50.00 *
Details
MAGE 212-220 (HLA-C*07:01) MAGE 212-220 (HLA-C*07:01)
This Peptide MAGE HLA-C*07:01 (EGDCAPEEK) is for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.
From €50.00 *
Details
HCMV pp65 (HLA-C*04:01) HCMV pp65 (HLA-C*04:01)
QYDPVAALFL (HLA-A*2402) is a single peptide for stimulation of T cells. The peptide from human cytomegalovirus (CMV) phosphoprotein (pp65) is synthesized as it is presented by the MHC class I HLA-A*2402 allele and can be used for...
From €50.00 *
Details
EBV BZLF-1 190-197 (HLA-B*08:01) EBV BZLF-1 190-197 (HLA-B*08:01)
Antigen peptide RAKFKQLL for stimulation of human EBV BZLF-1(190-197)-specific CD8+ T-cells. The peptide is synthesised as it is presented by the MHC class I HLA-B*0801 allele. RAKFKQLL is a linear peptidic epitope (epitope ID53128)...
From €50.00 *
Details
HERV-K Gag 155-163 (HLA-A*02:01) HERV-K Gag 155-163 (HLA-A*02:01)
Antigen Peptide Gag HLA-A*0201 (VIYPETLKL) for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.
From €50.00 *
Details
HERV-K Gag 139-147 (HLA-A*02:01) HERV-K Gag 139-147 (HLA-A*02:01)
Antigen Peptide Gag HLA-A*02:01 (VMAQSTQNV) for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.
From €50.00 *
Details
HERV-K Env 105-114 (HLA-A*02:01) HERV-K Env 105-114 (HLA-A*02:01)
QIFEASKAHL (HLA-A*0201) is a single peptide for stimulation of T cells. The peptide from human endogenous retrovirus type K (HERV-K) envelope (Env) is synthesized as it is presented by the MHC class I HLA-A*0201 allele and can be used...
From €50.00 *
Details
HIV p24-Gag 30-40 (HLA-B*57:01) HIV p24-Gag 30-40 (HLA-B*57:01)
KAFSPEVIPMF (HLA-B*57:01) is a single peptide for stimulation of T cells. The peptide from human immunodeficiency virus 1 (HIV-1) p24 group-specific antigen (Gag) is synthesized as it is presented by the MHC class I HLA-B*57:01 allele...
From €50.00 *
Details
HIV p24-Gag 263-272 (HLA-B*27:05) HIV p24-Gag 263-272 (HLA-B*27:05)
KRWIILGLNK is a linear peptidic epitope (epitope ID33250) studied as part of Gag-Pol polyprotein from Human immunodeficiency virus 1 and Gag polyprotein from Human immunodeficiency virus 1. This epitope has been studied for immune...
From €50.00 *
Details
EBV EBNA-3A 603-611 (HLA-A*03:01) EBV EBNA-3A 603-611 (HLA-A*03:01)
RLRAEAQVK is a linear peptidic epitope (epitope ID54728) studied as part of Epstein-Barr nuclear antigen 3 from Human herpesvirus 4 (Epstein Barr virus). This epitope has been studied for immune reactivity, tested in T cell assays and...
From €50.00 *
Details
EBV LMP2 356-364 (HLA-A*02:01) EBV LMP2 356-364 (HLA-A*02:01)
Antigen Peptide EBV LMP2 HLA-A*0201 (FLYALALLL) for stimulation of human EBV LMP2(356-364)-specific CD8+ T-cells. The peptide is synthesised as it is presented by the MHC class I HLA-A*0201 allele. LYALALLL is a linear peptidic epitope...
From €50.00 *
Details
EBV EBNA-1 407-417 (HLA-B*35:01) EBV EBNA-1 407-417 (HLA-B*35:01)
HPVGEADYFEY (HLA-B*3501) is a single peptide for stimulation of T cells. The peptide from human Epstein-Barr virus' (EBV) Epstein-Barr nuclear antigen 1 (EBNA-1) is synthesized as it is presented by the MHC class I HLA-B*3501 allele and...
From €50.00 *
Details
HPV 16 E7 49-57 (H-2 Db) HPV 16 E7 49-57 (H-2 Db)
RAHYNIVTF is a linear peptidic epitope studied as part of Protein E7 from Alphapapillomavirus 9 and Other Human papillomavirus protein from Human papillomavirus. This epitope is used for immune reactivity in, T cell assays, B cell assays...
From €50.00 *
Details
Influenza A NP 366-374 (H-2 Db) Influenza A NP 366-374 (H-2 Db)
ASNENMETM (H-2 Db) is a single peptide for stimulation of T cells. The peptide from Influenza nucleoprotein is synthesized as it is presented by the MHC class I H-2 Db allele and can be used for targeted in vitro generation and expansion...
From €50.00 *
Details
CD20 188-196 (HLA-A*02:01) CD20 188-196 (HLA-A*02:01)
SLFLGILSV is a linear peptidic epitope (epitope ID140742) studied as part of B-lymphocyte antigen CD20 from Homo sapiens (human), tested in T cell assays CD20 188-196 (HLA-A*02:01) SLFLGILSV for stimulation of T-cells. Single peptide...
From €50.00 *
Details
SIV Gag 181-189 (Mamu-A*01) SIV Gag 181-189 (Mamu-A*01)
From €50.00 *
Details
Bcl-2 214-223 (HLA-A*02:01) Bcl-2 214-223 (HLA-A*02:01)
Bcl-2 peptide 214-223 (HLA-A*0201) is a single peptide for stimulation of T cells. The peptide from B cell lymphoma 2 (Bcl-2) is synthesized as it is presented by the MHC class I HLA-A*0201 allele and can be used for targeted in vitro...
From €50.00 *
Details
CD22 antigen (HLA-A*02:01) CD22 antigen (HLA-A*02:01)
Antigen Peptide CD antigen HLA- A*0201 (PLSEGPHSL) for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays
From €50.00 *
Details
CD22 antigen 459-467 (HLA-A*02:01) CD22 antigen 459-467 (HLA-A*02:01)
D22 antigen(459-467) peptide SLPYHSQKL (HLA- A*02:01) for stimulation of T-cells. Single peptide (SLPYHSQKL) for stimulation of human CD22 antigen(459-467)-specific CD8+ T-cells.
From €50.00 *
Details
Influenza A PB1 591-599 (HLA-A*01:01) Influenza A PB1 591-599 (HLA-A*01:01)
VSDGGPNLY is a linear peptidic epitope (epitope ID70898) studied as part of RNA-directed RNA polymerase catalytic subunit from Influenza A virus. This epitope has been studied for immune reactivity, tested in T cell assays and MHC ligand...
From €50.00 *
Details
CD22 antigen 173-181 (HLA-A*02:01) CD22 antigen 173-181 (HLA-A*02:01)
CD22 antigen (173-181) peptide QLQWLLEGV (HLA- A*0201) for stimulation of T-cells. Single peptide (QLQWLLEGV) for stimulation of human CD22 antigen(173-181)-specific CD8+ T-cells.
From €50.00 *
Details
ADV hexon (HLA-B*35:01) ADV hexon (HLA-B*35:01)
ADV hexon peptide MPNRPNYIAF (HLA-B*35:01) for stimulation of T-cells. Single peptide (MPNRPNYIAF) for stimulation of human ADV hexon-specific CD8+ T-cells. The peptide is synthesised as it is presented by the MHC class I HLA-B*35:01 allele
From €50.00 *
Details
ADV hexon (HLA-B*07:02) ADV hexon (HLA-B*07:02)
ADV hexon peptide KPYSGTAYNAL (HLA-B*07:02) for stimulation of T-cells. Single peptide (KPYSGTAYNAL) for stimulation of human ADV hexon-specific CD8+ T-cells. The peptide is synthesised as it is presented by the MHC class I HLA-B*07:02...
From €50.00 *
Details
ADV hexon (HLA-A*24:02) ADV hexon (HLA-A*24:02)
ADV hexon peptide TYFSLNNKF (HLA-A*24:02) for stimulation of T-cells. Single peptide (TYFSLNNKF) for stimulation of human ADV hexon-specific CD8+ T-cells. The peptide is synthesised as it is presented by the MHC class IHLA-A*24:02 allele
From €50.00 *
Details
CEA 605-613 (HLA-A*02:01) CEA 605-613 (HLA-A*02:01)
CEA 605-613 peptide YLSGANLNL (HLA-A*0201) is a single peptide for stimulation of T cells. The peptide from Adenylyl Cyclase-Associated Protein 1 (CAP1) is synthesized as it is presented by the MHC class I HLA-A*0201 allele and can be...
From €50.00 *
Details
OVA-Q4H7(H-2 Kb) OVA-Q4H7(H-2 Kb)
Q4H7 peptide SIIQFEHL (H-2 Kb) for stimulation of T cells. Single peptide (SIIQFEHL) for stimulation of mouse Ovalbumin-specific CD8+ T cells. The peptide from Ovalbumin (OVA) variant Q4H7 is synthesized as it is presented by the MHC...
From €50.00 *
Details
Uty (H-2 Db) Uty (H-2 Db)
Antigen peptide WMHHNMLDI for stimulation of murine Uty-specific CD8+T-cells. The peptide is synthesised as it is presented by the MHC class I H-2 Db allele.
From €50.00 *
Details
MAGE-A1 161-169 (HLA-A*01:01) MAGE-A1 161-169 (HLA-A*01:01)
EADPTGHSY is a linear peptidic epitope (epitope ID11010) studied as part of Melanoma-associated antigen 1 from Homo sapiens (human). This epitope has been studied for immune reactivity, tested in T cell assays and MHC ligand assays
From €50.00 *
Details
HIV gag 197-205 (H-2 Kd) HIV gag 197-205 (H-2 Kd)
HIV gag peptide AMQMLKETI (H-2 Kd) is a single peptide for stimulation of T cells. The peptide from human immunodeficiency virus (HIV) group-specific antigen (Gag) is synthesized as it is presented by the MHC class I H-2 Kd allele and...
From €50.00 *
Details
Survivin 95-104 (HLA-A*02:01) Survivin 95-104 (HLA-A*02:01)
Survivin-derived peptide of ELTLGEFLKL sequence covering 95–104 and A*0201 molecule.Single peptide (ELTLGEFLKL) for stimulation of human Survivin -specific CD8+ T-cells. The peptide is synthesised as it is presented by the MHC class I...
From €50.00 *
Details
WT1 235-243 (HLA-A*24:02) WT1 235-243 (HLA-A*24:02)
Antigen peptide WT1 235-243 (HLA-A*24:02) CMTWNQMNL for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.
From €50.00 *
Details
gp100 280-288 (HLA-A*02:01) gp100 280-288 (HLA-A*02:01)
YLEPGPVTA is a linear peptidic epitope studied as part of Melanocyte protein PMEL from Homo sapiens (human). gp100 peptide YLEPGPVTA (HLA-A*02:01) for stimulation of human gp100-specific CD8+ T-cells. The peptide is synthesised as it is...
From €50.00 *
Details
MUC1 (HLA-B*07:02) MUC1 (HLA-B*07:02)
MUC1 peptide VPGWGIALL (HLA-B*07:02) is a single peptide for stimulation of T cells. The peptide from Mucin 1 (MUC1) is synthesized as it is presented by the MHC class I HLA-B*0702 allele and can be used for stimulation of...
From €50.00 *
Details
MUC1 (HLA-A*02:01) MUC1 (HLA-A*02:01)
Antigen Peptide Mucin-1 HLA-A*0201 for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays. MUC1 peptide STAPPVHNV (HLA-A*0201) is a single peptide for stimulation of T cells....
From €50.00 *
Details
WT1 (HLA-A*02:01) WT1 (HLA-A*02:01)
RMFPNAPYL is a linear peptidic epitope (epitope ID54882) studied as part of Wilms tumor protein from Homo sapiens (human). This epitope has been studied for immune reactivity, tested in T cell assays and MHC ligand assays WT-1 126-134...
From €50.00 *
Details
HM1.24-aa 126-134 (HLA-A*02:01) HM1.24-aa 126-134 (HLA-A*02:01)
KLQDASAEV is a linear peptidic epitope (epitope ID455519) studied as part of Bone marrow stromal antigen 2 from Homo sapiens (human), tested in MHC ligand assays. HM1.24 126-134 (HLA-A*02:01) KLQDASAEV for stimulation of T-cells. Single...
From €50.00 *
Details
HA-1 137-145 (HLA-A*02:01) His139 HA-1 137-145 (HLA-A*02:01) His139
Antigen Peptide HA-1 137-145 His139 (HLA-A*02:01) VLHDDLLEA for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays. VLHDDLLEA is a linear peptidic epitope (epitope ID136896)...
From €50.00 *
Details
LLO 91-99 (H-2 Kd) LLO 91-99 (H-2 Kd)
This peptide is a tetramer of biotinylated peptide with streptavidin mainly composed of L. monocytogenes-derived peptide of GYKDGNEYI sequence covering 91-99 and H-2Kd molecule. The pMHC tetramer recognizes mouse CD8 T cells, and can be...
From €50.00 *
Details
NY-ESO-1 157-165 (HLA-A*02:01) NY-ESO-1 157-165 (HLA-A*02:01)
NY-ESO-1 157-165 (HLA-A*02:01) peptide SLLMWITQV for stimulation of T-cells. Single peptide SLLMWITQV for stimulation of human NY-ESO-1-specific CD8+ T-cells SLLMWITQV is a linear peptidic epitope (epitope ID59283) studied as part of...
From €50.00 *
Details
gp100 209-217 (HLA-A*02:01) gp100 209-217 (HLA-A*02:01)
ITDQVPFSV is a linear peptidic epitope studied as part of Melanocyte protein PMEL from Homo sapiens (human) and Melanocyte protein PMEL from Mus musculus (mouse). Gp 100 209-217 peptide ITDQVPFSV (HLA-A*02:01) for stimulation of T-cells....
From €50.00 *
Details
gp100 209-217 mutant (HLA-A*02:01) 210M gp100 209-217 mutant (HLA-A*02:01) 210M
gp100 209-217 Pos. 210M (HLA-A*02:01) IMDQVPFSV is a linear peptidic epitope studied as part of Melanoma antigen preferentially expressed in tumors from Homo sapiens (human). This epitope has been studied for immune reactivity in several...
From €50.00 *
Details
HER-2/neu 689-697 (HLA-A*02:01) HER-2/neu 689-697 (HLA-A*02:01)
Her-2/neu peptide RLLQETELV (HLA-A*02:01) for stimulation of T-cells. Single peptide (RLLQETELV) for stimulation of human Her-2/neu-specific CD8+ T-cells.
From €50.00 *
Details
HER-2/neu 369-377 (HLA-A*02:01) HER-2/neu 369-377 (HLA-A*02:01)
KIFGSLAFL is a linear peptidic epitope studied as part of Receptor tyrosine-protein kinase erbB-2 from Rattus norvegicus (brown rat) and Receptor tyrosine-protein kinase erbB-2 from Homo sapiens (human). This epitope has been studied for...
From €50.00 *
Details
HBV core 18-27 (HLA-A*02:01) HBV core 18-27 (HLA-A*02:01)
FLPSDFFPSV is a linear peptidic epitope studied as part of Capsid protein from Hepatitis B virus and External core antigen from Hepatitis B virus. HBV core peptide FLPSDFFPSV (HLA-A*02:01) f for stimulation of human HBV core-specific...
From €50.00 *
Details
HIV-1 RT 476-484 (HLA-A*02:01) HIV-1 RT 476-484 (HLA-A*02:01)
ILKEPVHGV is a linear peptidic epitope studied as part of Gag-Pol polyprotein from Human immunodeficiency virus 1. HIV pol peptide ILKEPVHGV (HLA-A*02:01) for stimulation of human HIV pol-specific CD8+ T-cells. The peptide is synthesised...
From €50.00 *
Details
HIV-1 p17 Gag 77-85 (HLA-A*02:01) HIV-1 p17 Gag 77-85 (HLA-A*02:01)
SLYNTVATL is a linear peptidic epitope (epitope ID59613) studied as part of Gag polyprotein from Human immunodeficiency virus 1 and Gag-Pol polyprotein from Human immunodeficiency virus 1. This epitope has been studied for immune...
From €50.00 *
Details
Influenza MP 58-66 (HLA-A*02:01) Influenza MP 58-66 (HLA-A*02:01)
GILGFVFTL is a HLA-A2-restricted epitope from influenza matrix M1 protein.
From €50.00 *
Details
EBV BMLF-1 280-288 (HLA-A*0201) EBV BMLF-1 280-288 (HLA-A*0201)
EBV peptide GLCTLVAML (HLA-A*0201) for stimulation of T-cells. Single peptide (GLCTLVAML) for stimulation of human EBV BMLF-1(280-288) CD8+ T-cells. The peptide is synthesised as it is presented by the MHC class I HLA-A*0201 allele.
From €50.00 *
Details
3x FLAG Peptide 3x FLAG Peptide
From €170.00 *
Details
LCMV gp 276-286 (H-2 Db) LCMV gp 276-286 (H-2 Db)
This peptide is a tetramer of biotinylated peptide with streptavidin mainly composed of LCMV-derived peptide of SGVENPGGYCL sequence covering 276-286 and H-2Db molecule. The pMHC tetramer recognizes mouse CD8 T cells, and can be used in...
From €50.00 *
Details
HCV Polyprotein 1406-1415 (HLA-A*02:01) HCV Polyprotein 1406-1415 (HLA-A*02:01)
KLVALGINAV is a linear peptidic epitope studied as part of Genome polyprotein from Hepatitis C virus. Single peptide (KLVALGINAV) for stimulation of human HCV NS3 (1406-1415)-specific CD8+ T cells. The peptide is synthesised as it is...
From €50.00 *
Details
PPI 2-10 (HLA-A*02:01) PPI 2-10 (HLA-A*02:01)
ALWMRLLPL (HLA-A*0201) is a single peptide for stimulation of T cells. The peptide from preproinsulin (PPI) is synthesized as it is presented by the MHC class I HLA-A*0201 allele and can be used for targeted in vitro generation and...
From €50.00 *
Details
ADV Hexon 917-925 (HLA-A*02:01) ADV Hexon 917-925 (HLA-A*02:01)
Single peptide (YVLFEVFDV) for stimulation of human ADV Hexon (917-925)-specific CD8+ T cells. The peptide is synthesised as it is presented by the MHC class I HLA-A*02:01 allele. Lyophilized powder. Purity > 95 %, endotoxin free.
From €50.00 *
Details
Survivin 5-14 (HLA-A*02:01) Survivin 5-14 (HLA-A*02:01)
Single peptide (TLPPAWQPFL) for stimulation of human Survivin (5-14)-specific CD8+ T-cells. The peptide is synthesised as it is presented by the MHC class I HLA-A*02:01 allele. Delivery Format: The product is supplied freeze dried as...
From €50.00 *
Details
Cyclin A1 227-235 (HLA-A*02:01) Cyclin A1 227-235 (HLA-A*02:01)
Single peptide (FLDRFLSCM) for stimulation of human CyclinA1(227-235)-specific CD8+T cells
From €50.00 *
Details
HCMV pp65 265-275 (HLA-B*07:02) HCMV pp65 265-275 (HLA-B*07:02)
RPHERNGFTVL is a linear peptidic epitope (epitope ID55170) studied as part of 65 kDa phosphoprotein from Human herpesvirus 5 (Human cytomegalovirus). This epitope has been studied for immune reactivity, tested in T cell assays and MHC...
From €50.00 *
Details
CD79b 52-60 (HLA-A*02:01) CD79b 52-60 (HLA-A*02:01)
Antigen Peptide CD antigen HLA-A*0203 (TLKDGIIMI) for stimulation of antigen-specific T cells in T cell assays
From €50.00 *
Details
CD22-4 371-379 (HLA-A*02:01) CD22-4 371-379 (HLA-A*02:01)
SARS-CoV-2 peptide LLLDRLNQL (HLA-A*0201) for stimulation of T-cells. Single peptide (LLLDRLNQL) for stimulation of human SARS-CoV-2-specific CD8+ T-cells.
From €50.00 *
Details
FAP 735-744 (HLA-A*02:01) FAP 735-744 (HLA-A*02:01)
GLSGLSTNHL (HLA-A*0201) is a single peptide for stimulation of T cells. The peptide from fibroblast activation protein (FAP) is synthesized as it is presented by the MHC class I HLA-A*0201 allele and can be used for targeted in vitro...
From €50.00 *
Details
UTA2-1 248-256 (HLA-A*02:01) UTA2-1 248-256 (HLA-A*02:01)
Antigene peptide for stimulation of human UTA2-1(248-256)-specific CD8+T cells. The peptide is synthesised as it is presented by the MHC class I HLA-A*02:01 allele.
From €50.00 *
Details
Fibromodulin F4 226-235 (HLA-A*02:01) Fibromodulin F4 226-235 (HLA-A*02:01)
YLLDLSYNHL (HLA-A*0201) is a single peptide for stimulation of T cells. The peptide from tumor-associated antigen Fibromodulin F4 is synthesized as it is presented by the MHC class I HLA-A*0201 allele and can be used for targeted in...
From €50.00 *
Details
Fibromodulin F3 250-259 (HLA-A*02:01) Fibromodulin F3 250-259 (HLA-A*02:01)
Antigen Peptide Fibromodulin HLA-A*02:01 (YMEHNNVYTV) for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.
From €50.00 *
Details
Fibromodulin F2 206-215 (HLA-A*02:01) Fibromodulin F2 206-215 (HLA-A*02:01)
Antigen Peptide Fibromodulin HLA-A*02:01 (YLQHNEIQEV) for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.
From €50.00 *
Details
Fibromodulin F1 7-17 (HLA-A*02:01) Fibromodulin F1 7-17 (HLA-A*02:01)
Antigen Peptide Fibromodulin HLA-A*02:01 (LLLAGLFSL) for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.
From €50.00 *
Details
HsPSMA 634-642 (H-2 Db) HsPSMA 634-642 (H-2 Db)
SAVKNFTEI (H-2 Db) is a single peptide for stimulation of T cells. The peptide from HsPSMA is synthesized as it is presented by the MHC class I H-2 Db allele and can be used for targeted in vitro generation and expansion of...
From €50.00 *
Details
MAGE 212-220 (HLA-C*07:01) MAGE 212-220 (HLA-C*07:01)
This Peptide MAGE HLA-C*07:01 (EGDCAPEEK) is for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.
From €50.00 *
Details
HCMV pp65 341-349 (HLA-A*24:02/HLA-A*23:01) HCMV pp65 341-349 (HLA-A*24:02/HLA-A*23:01)
HCMV pp65 341-349 (HLA-A*24:02/HLA-A*23:01) QYDPVAALF for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays. QYDPVAALF is a linear peptidic epitope (epitope ID52886) studied...
From €50.00 *
Details
EBV BZLF-1 190-197 (HLA-B*08:01) EBV BZLF-1 190-197 (HLA-B*08:01)
Antigen peptide RAKFKQLL for stimulation of human EBV BZLF-1(190-197)-specific CD8+ T-cells. The peptide is synthesised as it is presented by the MHC class I HLA-B*0801 allele. RAKFKQLL is a linear peptidic epitope (epitope ID53128)...
From €50.00 *
Details
HERV-K Gag 155-163 (HLA-A*02:01) HERV-K Gag 155-163 (HLA-A*02:01)
Antigen Peptide Gag HLA-A*0201 (VIYPETLKL) for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.
From €50.00 *
Details
HERV-K Gag 139-147 (HLA-A*02:01) HERV-K Gag 139-147 (HLA-A*02:01)
Antigen Peptide Gag HLA-A*02:01 (VMAQSTQNV) for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.
From €50.00 *
Details
HERV-K Env 105-114 (HLA-A*02:01) HERV-K Env 105-114 (HLA-A*02:01)
QIFEASKAHL (HLA-A*0201) is a single peptide for stimulation of T cells. The peptide from human endogenous retrovirus type K (HERV-K) envelope (Env) is synthesized as it is presented by the MHC class I HLA-A*0201 allele and can be used...
From €50.00 *
Details
HIV p24-Gag 30-40 (HLA-B*57:01) HIV p24-Gag 30-40 (HLA-B*57:01)
This peptide is a tetramer of biotinylated peptide with streptavidin mainly composed of HIV-1 gag-derived peptide of KAFSPEVIPMF covering 162-172 and B*57:03 molecule. The pMHC tetramer recognizes CD8 T cells, and can be used in the...
From €50.00 *
Details
HIV p24-Gag 263-272 (HLA-B*27:05) HIV p24-Gag 263-272 (HLA-B*27:05)
KRWIILGLNK is a linear peptidic epitope (epitope ID33250) studied as part of Gag-Pol polyprotein from Human immunodeficiency virus 1 and Gag polyprotein from Human immunodeficiency virus 1. This epitope has been studied for immune...
From €50.00 *
Details
EBV LMP2 356-364 (HLA-A*02:01) EBV LMP2 356-364 (HLA-A*02:01)
Antigen Peptide EBV LMP2 HLA-A*0201 (FLYALALLL) for stimulation of human EBV LMP2(356-364)-specific CD8+ T-cells. The peptide is synthesised as it is presented by the MHC class I HLA-A*0201 allele. LYALALLL is a linear peptidic epitope...
From €50.00 *
Details
EBV EBNA-3A 603-611 (HLA-A*03:01) EBV EBNA-3A 603-611 (HLA-A*03:01)
RLRAEAQVK is a linear peptidic epitope (epitope ID54728) studied as part of Epstein-Barr nuclear antigen 3 from Human herpesvirus 4 (Epstein Barr virus). This epitope has been studied for immune reactivity, tested in T cell assays and...
From €50.00 *
Details
CD20 188-196 (HLA-A*02:01) CD20 188-196 (HLA-A*02:01)
SLFLGILSV is a linear peptidic epitope (epitope ID140742) studied as part of B-lymphocyte antigen CD20 from Homo sapiens (human), tested in T cell assays CD20 188-196 (HLA-A*02:01) SLFLGILSV for stimulation of T-cells. Single peptide...
From €50.00 *
Details
SIVmag Gag 19-27 (Mamu-A*01) SIVmag Gag 19-27 (Mamu-A*01)
MHC I-Strep Mamu-A*01; SIVmag Gag (181-189) (CTPYDINQM) is a recombinantly expressed MHC class I molecule that presents a peptide from a simian immunodeficiency virus (SIV) group-specific antigen.
From €50.00 *
Details
Bcl-2 214-223 (HLA-A*02:01) Bcl-2 214-223 (HLA-A*02:01)
Bcl-2 peptide WLSLKTLLSL (HLA-A*0201) is a single peptide for stimulation of T cells. The peptide from B cell lymphoma 2 (Bcl-2) is synthesized as it is presented by the MHC class I HLA-A*0201 allele and can be used for targeted in vitro...
From €50.00 *
Details
CD22 antigen (HLA-A*02:01) CD22 antigen (HLA-A*02:01)
Antigen Peptide CD antigen HLA- A*0201 (PLSEGPHSL) for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays
From €50.00 *
Details
CD22 antigen 459-467 (HLA-A*02:01) CD22 antigen 459-467 (HLA-A*02:01)
D22 antigen(459-467) peptide SLPYHSQKL (HLA- A*02:01) for stimulation of T-cells. Single peptide (SLPYHSQKL) for stimulation of human CD22 antigen(459-467)-specific CD8+ T-cells.
From €50.00 *
Details
CD22 antigen 173-181 (HLA-A*02:01) CD22 antigen 173-181 (HLA-A*02:01)
CD22 antigen(173-181) peptide QLQWLLEGV (HLA- A*0201) for stimulation of T-cells. Single peptide (QLQWLLEGV) for stimulation of human CD22 antigen(173-181)-specific CD8+ T-cells.
From €50.00 *
Details
ADV hexon (HLA-B*35:01) ADV hexon (HLA-B*35:01)
ADV hexon peptide MPNRPNYIAF (HLA-B*35:01) for stimulation of T-cells. Single peptide (MPNRPNYIAF) for stimulation of human ADV hexon-specific CD8+ T-cells. The peptide is synthesised as it is presented by the MHC class I HLA-B*35:01 allele
From €50.00 *
Details
ADV hexon 114 -124 (HLA-B*07:02) ADV hexon 114 -124 (HLA-B*07:02)
Single peptide (KPYSGTAYNAL) for stimulation of human ADV Hexon (114-124)-specific CD8+ T cells. The peptide is synthesised as it is presented by the MHC class I HLA-B*07:02 allele. Lyophilized powder. Purity > 95 %, endotoxin free.
From €50.00 *
Details
ADV hexon 37-45 (HLA-A*24:02) ADV hexon 37-45 (HLA-A*24:02)
Single peptide (TYFSLNNKF) for stimulation of human ADV Hexon (37-45)-specific CD8+ T cells. The peptide is synthesised as it is presented by the MHC class I HLA-A*24:02 allele. Lyophilized powder. Purity > 95 %, endotoxin free.
From €50.00 *
Details
Influenza NP 147-155 (H-2Kd) Influenza NP 147-155 (H-2Kd)
TYQRTRALV is a linear peptidic epitope studied as part of Nucleoprotein from Influenza A virus. This epitope has been studied for immune reactivity, tested in T cell assays, B cell assays, MHC ligand assays
From €50.00 *
Details
CEA 605-613 (HLA-A*02:01) CEA 605-613 (HLA-A*02:01)
This peptide is a tetramer of biotinylated peptide with streptavidin mainly composed of CEA-derived peptide of YLSGANLNL sequence covering 605-613 and A*02:01 molecule. The pMHC tetramer recognizes human CD8 T cells, and can be used in...
From €50.00 *
Details
OVA-Q4H7 (H-2 Kb) OVA-Q4H7 (H-2 Kb)
Q4H7 peptide SIIQFEHL (H-2 Kb) for stimulation of T cells. Single peptide (SIIQFEHL) for stimulation of mouse Ovalbumin-specific CD8+ T cells. The peptide is synthesised as it is presented by the MHC class I H-2 Kb allele.
From €50.00 *
Details
Uty (H-2 Db) Uty (H-2 Db)
Antigen peptide WMHHNMLDI for stimulation of murine Uty-specific CD8+T-cells. The peptide is synthesised as it is presented by the MHC class I H-2 Db allele.
From €50.00 *
Details
MAGE-A1 161-169 (HLA-A*01:01) MAGE-A1 161-169 (HLA-A*01:01)
EADPTGHSY is a linear peptidic epitope (epitope ID11010) studied as part of Melanoma-associated antigen 1 from Homo sapiens (human). This epitope has been studied for immune reactivity, tested in T cell assays and MHC ligand assays
From €50.00 *
Details <